Corporate News

PDMR/Director Dealing

08 June 2022

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces that, following the general meeting held on 6 June 2022 and Admission on 8 June 2022, the following Directors participated in the Fundraising and their resultant holdings are detailed in the table below.


Director Board Position Number of
Shares at the
Issue Price
Amount (£) Resultant holding Resultant
holding of
Enlarged Issued Share Capital
Simon Douglas1 Chairman 500,000 20,000 500,000 0.21%
Jag Grewal2 CEO 500,000 20,000 735,746 0.31%
Chris Lea3 CFO 500,000 20,000 500,000 0.21%
Jeremy Millard4 Non-Executive Director 500,000 20,000 1,025,000 0.43%

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 13 May 2022.



Omega Diagnostics Group PLC
Jag Grewal Chief Executive Officervia Walbrook PR
Chris Lea, Chief Financial Officer  
finnCap LtdTel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)  
Alice Lane/ Harriet Ward (ECM)  
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258


About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health. 


Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them


1   Details of the person discharging managerial responsibilities / person closely associated  
Name 1) Simon Douglas
2)     Jag Grewal
3)     Chris Lea
4)     Jeremy Millard
2 Reason for the notification
1)     Chairman
2)     Chief Executive Officer
3)     Chief Financial Officer
4)     Non-Executive Director
b) Initial notification /Amendment   Initial Notification
3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)   Name   Omega Diagnostics Group Plc
b)   LEI   2138007U9P4BTZTYIR92
4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
Description of the financial
instrument, type of instrument
 Identification code  
Ordinary Shares of 4 pence each  
b)   Nature of the transaction   Purchase of Shares
Price(s) and volume(s)
  Price(s) Volume(s)  
1) £0.04 500,000
   2) £0.04 500,000  
   3) £0.04 500,000  
£0.04 500,000  
d) Aggregated information  
-Aggregated volume  
- Price  
N/A - single transaction for each Director or PCA
e)   Date of the transaction  6 May 2022
f)   Place of the transaction London Stock Exchange (AIM)

Sign up for Investor Alerts